Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.
about
New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Role of Gene Therapy in Pancreatic Cancer-A Review.A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.Viral Vectors in Gene Therapy.
P2860
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Genomic Signature of the Natur ...... eclinical and Clinical Trials.
@en
type
label
Genomic Signature of the Natur ...... eclinical and Clinical Trials.
@en
prefLabel
Genomic Signature of the Natur ...... eclinical and Clinical Trials.
@en
P2093
P2860
P356
P1476
Genomic Signature of the Natur ...... reclinical and Clinical Trials
@en
P2093
Branko Aleksic
Hasegawa Hitoki
Hideki Kasuya
Itzel Bustos-Villalobos
Maki Tanaka
Nobuaki Mukoyama
Noriyuki Miyajima
Seiji Sumigama
Taishi Morimoto
Toru Ichinose
P2860
P356
10.3389/FONC.2017.00149
P577
2017-07-14T00:00:00Z